Back
Galmed Pharmaceuticals Ltd. 10K Form
Sell
32
GLMD
Galmed Pharmaceuticals Ltd.
Last Price:
$0.87
Seasonality Move:
-10.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GLMD News And Ratings
See the #1 stock for the next 7 days that we like better than GLMD
GLMD Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-1.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.49 |
| Price / Book: | 0.25 |
Profitability
| EPS (TTM): | -3.52620 |
|---|---|
| Net Income (TTM): | $-8.7M |
| Gross Margin: | $-83K |
| Return on Equity: | -47.66% |
| Return on Assets: | -42.37% |
Galmed Pharmaceuticals Ltd. Earnings Forecast
Key Galmed Pharmaceuticals Ltd. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 7 years.
Galmed Pharmaceuticals Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GLMD |
| CUSIP: | M47238 |
| Website: | galmedpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.98 |
| Quick Ratio: | 7.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GLMD Technical Analysis vs Fundamental Analysis
Sell
32
Galmed Pharmaceuticals Ltd. (GLMD)
is a Sell
Is Galmed Pharmaceuticals Ltd. a Buy or a Sell?
-
Galmed Pharmaceuticals Ltd. stock is rated a SellThe current Galmed Pharmaceuticals Ltd. [GLMD] share price is $0.88. The Score for GLMD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.